TrialNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2022

Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058.

Pejman Sehatpour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.